FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to ...
FRANKLIN LAKES, N.J., May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of its new, fully ...
They say good things happen in threes, and BD seems to be hoping that adage rings true for its Cor molecular diagnostic platform. Two years after the automated lab-testing system made its European ...
As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...
Learn how a large, multi site study supports laboratory adoption of extragenital CT/NG testing on an automated, high throughput platform. We’ll review study design (remnant specimens; composite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results